
Global Darbepoetin Alfa Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031
Description
Summary
Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
According to APO Research, The global Darbepoetin Alfa market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Darbepoetin Alfa is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Darbepoetin Alfa is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Darbepoetin Alfa is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Darbepoetin Alfa is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Darbepoetin Alfa include Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Novartis and 3SBio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Darbepoetin Alfa, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Darbepoetin Alfa, also provides the sales of main regions and countries. Of the upcoming market potential for Darbepoetin Alfa, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Darbepoetin Alfa sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Darbepoetin Alfa market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Darbepoetin Alfa sales, projected growth trends, production technology, application and end-user industry.
Darbepoetin Alfa Segment by Company
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Novartis
3SBio
Darbepoetin Alfa Segment by Type
Epogen
Procrit
Aranesp
Others
Darbepoetin Alfa Segment by Application
Patients with Chronic Kidney Disease
Patients with Cancer
Others
Darbepoetin Alfa Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Darbepoetin Alfa market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Darbepoetin Alfa and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Darbepoetin Alfa.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Darbepoetin Alfa market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Darbepoetin Alfa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Darbepoetin Alfa in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Darbepoetin Alfa in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Darbepoetin alfa (INN) is a re-engineered form of erythropoietin containing 5 amino acid changes (N30, T32, V87, N88, T90) resulting in the creation of 2 new sites for N-linked carbohydrate addition. It has a 3-fold longer serum half-life compared to epoetin alpha and epoetin beta. It stimulates erythropoiesis (increases red blood cell levels) by the same mechanism as rHuEpo (binding and activating the Epo receptor) and is used to treat anemia, commonly associated with chronic renal failure and cancer chemotherapy.
According to APO Research, The global Darbepoetin Alfa market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Darbepoetin Alfa is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Darbepoetin Alfa is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The China market for Darbepoetin Alfa is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Darbepoetin Alfa is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Darbepoetin Alfa include Amgen, Johnson & Johnson, Kyowa Hakko Kirin, Novartis and 3SBio, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Darbepoetin Alfa, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.
This report researches the key producers of Darbepoetin Alfa, also provides the sales of main regions and countries. Of the upcoming market potential for Darbepoetin Alfa, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Darbepoetin Alfa sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Darbepoetin Alfa market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Darbepoetin Alfa sales, projected growth trends, production technology, application and end-user industry.
Darbepoetin Alfa Segment by Company
Amgen
Johnson & Johnson
Kyowa Hakko Kirin
Novartis
3SBio
Darbepoetin Alfa Segment by Type
Epogen
Procrit
Aranesp
Others
Darbepoetin Alfa Segment by Application
Patients with Chronic Kidney Disease
Patients with Cancer
Others
Darbepoetin Alfa Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Darbepoetin Alfa market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Darbepoetin Alfa and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Darbepoetin Alfa.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Darbepoetin Alfa market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Darbepoetin Alfa manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Darbepoetin Alfa in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Darbepoetin Alfa in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
188 Pages
- 1 Market Overview
- 1.1 Product Definition
- 1.2 Global Darbepoetin Alfa Market Size, 2020 VS 2024 VS 2031
- 1.3 Global Darbepoetin Alfa Market Size Estimates and Forecasts (2020-2031)
- 1.4 Global Darbepoetin Alfa Sales Estimates and Forecasts (2020-2031)
- 1.5 Global Darbepoetin Alfa Market Average Price (2020-2031)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 2 Global Darbepoetin Alfa Market Dynamics
- 2.1 Darbepoetin Alfa Industry Trends
- 2.2 Darbepoetin Alfa Industry Drivers
- 2.3 Darbepoetin Alfa Industry Opportunities and Challenges
- 2.4 Darbepoetin Alfa Industry Restraints
- 3 Darbepoetin Alfa Market by Manufacturers
- 3.1 Global Darbepoetin Alfa Revenue by Manufacturers (2020-2025)
- 3.2 Global Darbepoetin Alfa Sales by Manufacturers (2020-2025)
- 3.3 Global Darbepoetin Alfa Average Sales Price by Manufacturers (2020-2025)
- 3.4 Global Darbepoetin Alfa Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
- 3.5 Global Darbepoetin Alfa Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Darbepoetin Alfa Manufacturers, Product Type & Application
- 3.7 Global Darbepoetin Alfa Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Darbepoetin Alfa Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Darbepoetin Alfa Players Market Share by Revenue in 2024
- 3.8.3 2024 Darbepoetin Alfa Tier 1, Tier 2, and Tier 3
- 4 Darbepoetin Alfa Market by Type
- 4.1 Darbepoetin Alfa Type Introduction
- 4.1.1 Epogen
- 4.1.2 Procrit
- 4.1.3 Aranesp
- 4.1.4 Others
- 4.2 Global Darbepoetin Alfa Sales by Type
- 4.2.1 Global Darbepoetin Alfa Sales by Type (2020 VS 2024 VS 2031)
- 4.2.2 Global Darbepoetin Alfa Sales by Type (2020-2031)
- 4.2.3 Global Darbepoetin Alfa Sales Market Share by Type (2020-2031)
- 4.3 Global Darbepoetin Alfa Revenue by Type
- 4.3.1 Global Darbepoetin Alfa Revenue by Type (2020 VS 2024 VS 2031)
- 4.3.2 Global Darbepoetin Alfa Revenue by Type (2020-2031)
- 4.3.3 Global Darbepoetin Alfa Revenue Market Share by Type (2020-2031)
- 5 Darbepoetin Alfa Market by Application
- 5.1 Darbepoetin Alfa Application Introduction
- 5.1.1 Patients with Chronic Kidney Disease
- 5.1.2 Patients with Cancer
- 5.1.3 Others
- 5.2 Global Darbepoetin Alfa Sales by Application
- 5.2.1 Global Darbepoetin Alfa Sales by Application (2020 VS 2024 VS 2031)
- 5.2.2 Global Darbepoetin Alfa Sales by Application (2020-2031)
- 5.2.3 Global Darbepoetin Alfa Sales Market Share by Application (2020-2031)
- 5.3 Global Darbepoetin Alfa Revenue by Application
- 5.3.1 Global Darbepoetin Alfa Revenue by Application (2020 VS 2024 VS 2031)
- 5.3.2 Global Darbepoetin Alfa Revenue by Application (2020-2031)
- 5.3.3 Global Darbepoetin Alfa Revenue Market Share by Application (2020-2031)
- 6 Global Darbepoetin Alfa Sales by Region
- 6.1 Global Darbepoetin Alfa Sales by Region: 2020 VS 2024 VS 2031
- 6.2 Global Darbepoetin Alfa Sales by Region (2020-2031)
- 6.2.1 Global Darbepoetin Alfa Sales by Region (2020-2025)
- 6.2.2 Global Darbepoetin Alfa Sales Forecasted by Region (2025-2030)
- 6.3 North America
- 6.3.1 North America Darbepoetin Alfa Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.3.2 North America Darbepoetin Alfa Sales by Country (2020-2031)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Darbepoetin Alfa Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.4.2 Europe Darbepoetin Alfa Sales by Country (2020-2031)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Darbepoetin Alfa Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.5.2 Asia Pacific Darbepoetin Alfa Sales by Country (2020-2031)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Darbepoetin Alfa Sales Growth Rate by Country: 2020 VS 2024 VS 2031
- 6.6.2 South America, Middle East and Africa Darbepoetin Alfa Sales by Country (2020-2031)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
- 7 Global Darbepoetin Alfa Revenue by Region
- 7.1 Global Darbepoetin Alfa Revenue by Region
- 7.1.1 Global Darbepoetin Alfa Revenue by Region: 2020 VS 2024 VS 2031
- 7.1.2 Global Darbepoetin Alfa Revenue by Region (2020-2025)
- 7.1.3 Global Darbepoetin Alfa Revenue by Region (2026-2031)
- 7.1.4 Global Darbepoetin Alfa Revenue Market Share by Region (2020-2031)
- 7.2 North America
- 7.2.1 North America Darbepoetin Alfa Revenue (2020-2031)
- 7.2.2 North America Darbepoetin Alfa Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.3 Europe
- 7.3.1 Europe Darbepoetin Alfa Revenue (2020-2031)
- 7.3.2 Europe Darbepoetin Alfa Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Darbepoetin Alfa Revenue (2020-2031)
- 7.4.2 Asia-Pacific Darbepoetin Alfa Revenue Share by Country: 2020 VS 2024 VS 2031
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Darbepoetin Alfa Revenue (2020-2031)
- 7.5.2 South America, Middle East and Africa Darbepoetin Alfa Revenue Share by Country: 2020 VS 2024 VS 2031
- 8 Company Profiles
- 8.1 Amgen
- 8.1.1 Amgen Comapny Information
- 8.1.2 Amgen Business Overview
- 8.1.3 Amgen Darbepoetin Alfa Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.1.4 Amgen Darbepoetin Alfa Product Portfolio
- 8.1.5 Amgen Recent Developments
- 8.2 Johnson & Johnson
- 8.2.1 Johnson & Johnson Comapny Information
- 8.2.2 Johnson & Johnson Business Overview
- 8.2.3 Johnson & Johnson Darbepoetin Alfa Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.2.4 Johnson & Johnson Darbepoetin Alfa Product Portfolio
- 8.2.5 Johnson & Johnson Recent Developments
- 8.3 Kyowa Hakko Kirin
- 8.3.1 Kyowa Hakko Kirin Comapny Information
- 8.3.2 Kyowa Hakko Kirin Business Overview
- 8.3.3 Kyowa Hakko Kirin Darbepoetin Alfa Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.3.4 Kyowa Hakko Kirin Darbepoetin Alfa Product Portfolio
- 8.3.5 Kyowa Hakko Kirin Recent Developments
- 8.4 Novartis
- 8.4.1 Novartis Comapny Information
- 8.4.2 Novartis Business Overview
- 8.4.3 Novartis Darbepoetin Alfa Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.4.4 Novartis Darbepoetin Alfa Product Portfolio
- 8.4.5 Novartis Recent Developments
- 8.5 3SBio
- 8.5.1 3SBio Comapny Information
- 8.5.2 3SBio Business Overview
- 8.5.3 3SBio Darbepoetin Alfa Sales, Price, Revenue and Gross Margin (2020-2025)
- 8.5.4 3SBio Darbepoetin Alfa Product Portfolio
- 8.5.5 3SBio Recent Developments
- 9 Value Chain and Sales Channels Analysis
- 9.1 Darbepoetin Alfa Value Chain Analysis
- 9.1.1 Darbepoetin Alfa Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Darbepoetin Alfa Production Mode & Process
- 9.2 Darbepoetin Alfa Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Darbepoetin Alfa Distributors
- 9.2.3 Darbepoetin Alfa Customers
- 10 Concluding Insights
- 11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.